Rina Kashi
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
-
- Tryptophan and brain disorders
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 9
-
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Rosalyn D. Blumenthal (9 shared papers)David M. Goldenberg (7 shared papers)Robert M. Sharkey (7 shared papers)R M Sharkey (2 shared papers)Esther Hurwitz (5 shared papers)David M. Goldenberg (2 shared papers)Rimona Margalit (1 shared paper)Dan Peer (1 shared paper)
- Journals
- International Journal of Cancer (6 papers)Cancer Immunology Immunotherapy (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Cancer Letters (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesIsraelNetherlands
In The Last Decade
Rina Kashi
19 papers receiving 576 citations
Peers
Comparison fields: 5 of 78
- Radiology, Nuclear Medicine and Imaging 277
- Biological Psychiatry 30
- Pathology and Forensic Medicine 86
- Oncology 119
- Immunology 92
Countries citing papers authored by Rina Kashi
This map shows the geographic impact of Rina Kashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Kashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Kashi more than expected).
Fields of papers citing papers by Rina Kashi
This network shows the impact of papers produced by Rina Kashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Kashi. The network helps show where Rina Kashi may publish in the future.
Co-authors
The 25 scholars most cited alongside Rina Kashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 118 | |
| 2 | 1977 | 79 | |
| 3 | 1991 | 49 | |
| 4 | 1989 | 45 | |
| 5 | Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts. | 1994 | 45 |
| 6 | 2008 | 41 | |
| 7 | 1995 | 30 | |
| 8 | 1989 | 27 | |
| 9 | 1985 | 23 | |
| 10 | 1991 | 20 | |
| 11 | 1992 | 19 | |
| 12 | 1997 | 19 | |
| 13 | A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine. | 2014 | 17 |
| 14 | 1991 | 14 | |
| 15 | 1983 | 14 | |
| 16 | 1983 | 14 | |
| 17 | 1986 | 11 | |
| 18 | 1982 | 11 | |
| 19 | 2014 | 1 |
About Rina Kashi
Rina Kashi is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Oncology and Genetics, having authored 19 papers that have together received 597 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (9 papers), Glycosylation and Glycoproteins Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer-related Molecular Pathways (2 papers), Immunotherapy and Immune Responses (2 papers) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (277 citations), Biological Psychiatry (30 citations), Pathology and Forensic Medicine (86 citations), Oncology (119 citations) and Immunology (92 citations). Rina Kashi has collaborated with scholars based in United States, Israel and Netherlands. Frequent co-authors include Rosalyn D. Blumenthal, David M. Goldenberg, Robert M. Sharkey, R M Sharkey, Esther Hurwitz, David M. Goldenberg, Rimona Margalit, Dan Peer, I. Nir and T. CORDOVA. Their work appears in journals such as International Journal of Cancer, Cancer Immunology Immunotherapy, JNCI Journal of the National Cancer Institute, Cancer Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.